Fernández-Ramos, David
Fernández-Tussy, Pablo
Lopitz-Otsoa, Fernando
Gutiérrez-de-Juan, Virginia
Navasa, Nicolás
Barbier-Torres, Lucía
Zubiete-Franco, Imanol
Simón, Jorge
Fernández, Agustín F.
Arbelaiz, Ander
Aransay, Ana M. http://orcid.org/0000-0002-8271-612X
Lavín, José Luis
Beraza, Naiara
Perugorria, María J.
Banales, Jesus M.
Villa, Erica http://orcid.org/0000-0001-6388-7022
Fraga, Mario F.
Anguita, Juan http://orcid.org/0000-0003-2061-7182
Avila, Matias A.
Berasain, Carmen
Iruzibieta, Paula
Crespo, Javier
Lu, Shelly C.
Varela-Rey, Marta
Mato, José M.
Delgado, Teresa C.
Martínez-Chantar, María L.
Article History
Received: 1 June 2018
Revised: 29 August 2018
Accepted: 31 August 2018
First Online: 20 September 2018
Conflict of interest
: M.L. Martínez-Chantar: Consultant/Advisory Board for Mitotherapeutix LLC. J. Mato: Consultant/Advisory Board for Abbott and Galmed, owns stocks for OWL. The other authors declare that they have no conflict of interest.